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THE THROMBOTIC PHENOMENON:
CONSIDiRATION OF THi MECHANISM OF ITS PRODUCTION

AND THi CLINICAL IMPLICATIONS
I.

INTRODUCTION

Thrombosis may be defined as the formation of an
intravital partial or complete obstruction of a blood
vessel by a solid or compact mass of blood.
thus formed is called a thrombus.

The plug

Its genesis is de-

pendent upon changes in pre-existent constituents of the
blood:

in cellular elements or in plasma or in both.

Thrombosis more commonly occurs in veins but may also
be found in capillaries, arteries, and heart.

This

phenomenon is preceded or accompanied by disturbances
in the chemical composition or the circulation of the
blood or results from changes in the endothelial lining
of the vascular wall.
Thrombosis is commonly found in adults but rarely
in children; it is somewhat more frequent in women than
in men.

In 1915 McLean (76) noted a rising incidence

of thrombosis which he attributed to increasing amounts

-2-

of surgery.

Silberberg (106), however, suggests that a

careful review of statistics of this subject reveals
temporary increases in the occurrence of thrombi and
that increases observed at any one time may be just the
reflection of a cyclic variation.

Racial differences

in susceptibility to thrombosis have been established-e.g., iuropeans in China exhibit a greater tendency
toward thrombi-formation than do the natives .
The original concept of thrombosis, that it was the
process of intravascular coagulation, is over 2000 years
old (106).

Hippocrates and Galen used the Greek term

from which our word thrombosis is derived to describe
·blood-coagulation, especially that following hemorrhage
into the tissues .

Diocles, in his discussion of the

vascular system, stated that an obstruction in the course
of a vessel may accompany inflammatory processes.
Baillie and Bouchut found a relationship between stasis
and thrombosis .

Cruveilhier considered a thrombus as a

fibrinous exudation on the part of the vascular wall.
Rokitansky, however, placed importance on chemical
changes of the blood itself leading to a surplus of
fibrin and consequent increased coaguability.

Virchow

held for the spontaneous development of intravascular
clotting due to local or general circulatory disturbances .

-3independently of cnemical or inflammatory changes in
tne blood, thus emphasizing the significance of mechanical factors in the formation of thrombi.

Tnroughout

tne years then there have been advanced various views
concerning the etiology of thrombosis, tne emphasis
shifting from tne chemical to tne physical hypotheses
depending upon the general pathological concepts
predominating in the particular period.
The clinical significance of tne thrombotic phenomenon becomes evident upon brief reflection of the
physiological role served by the blood and the importance
of the integrity of its supply.

The vascular system has

developed with the evolutionary process to its present
form so that every cell is properly bathed in fluid,
constantly changing, which serves the respiratory, nutritive, excretory, protective, and regulatory functions of
tnese protoplasmic units.

The system is a closed one,

the blood being forced along the arteries by the pumping action of the heart to the minute capillary bed
where t he interchange between plasma and tissue fluid
occurs; the blood then collects in the venous channels
and returns to the heart .

Oxygen is replenished and

waste carbon dioxide excreted by the lungs, food substances are fed into tne bloodstream from the gut and

-4-liver, and other waste products are removed by kidney,
liver, and skin.

Thus the very existence of tne indi-

vidual cells is dependent upon an intact blood supply.
Wha~ happens then when a vessel 1s obstructed?

If

an artery, the part supplied by it loses its allotment
of blood, assuming that no adequate collateral supply
is available, and suffers from anemia.

If a vein, the

return channel of the blood is impaired and the part in
question becomes congested and edematous.

If the ob-

struction is complete and long enougn continued, the
affected area undergoes infarction.

At times tne

thrombus enlarges and obstructs other vessels; mul tiple
thrombi may develop consecutively in various places , the
so-called thrombosis migrans.

Tne greatest source of

danger however, is the possibility that the thrombus,
in whole or in part, might break loose and be carried
by the bloodstream to otner, remote parts of the body
where new symptoms will occur.

Such a free-floating

blood clot is known as an embolus.

A large venous embo-

lus will lodge in the pulmonary artery and cause asphyxia and sudden death or massive pulmonary infarction.
Arterial emboli may be scattered to many smaller vessels
and produce multiple infarctions.

A venous embolus

sometime s slips into the arterial side of the circulation

-5through a patent foramen ovale or an interventricular
septal defect.

Retrograde movement of some emboli may

be due to pressure changes within the venous channels
coincident with the respiratory cycle.

The possibility

also exists that a bloodclot, which provides an excellent culture medium for micro-organisms, may serve as a
focal point for local suppuration, pyemia, or general
septicemia.

Thus tnrombosis offers many problems of

clinical interest.
The nature of thrombosis has been the subject of
controversy.

The observation that most thrombi are com-

posed mainly of a fibrinous network, resembling coagulation in vitro, has led to the assumption by some
investigators that the intravascular clot is altogether
a coagulative process.

Others have noted, however, that

agglutination of normal cellular elements occurs independently of the fibrin-producing mechanism anct have
thus identified a thrombus of a different sort. -In
truth, it snould be appreciated tnat thrombosis is a
complex pnenomenon, tne full understanding of which
requires the analysis of the following three principles,
their significance and their mutual relationship:
1.

The coagulation of the plasma .

2.

The role of coagulation-inhibiting substances.

3.

The agglutination of cellular elements.

-6Based on a survey of the literature on thrombosis,
this paper aims to prove the thesis that the normally
present and circulating blood constituents, given the
proper stimulus, are sufficient in themselves to produce
a thrombus and that in the incipiency of this thrombus
agglutination is of greater i mportance than coagulation.
Clinical implications of this thesis are presented.

II.

PHYSIOLOGICAL PATHOLOGY

Since the work of iahn (132), Hayem (49), Eberth
and Schimmelbusch (36); and Welch (124), the medical
world had been cognizant of the importance of platelets
and leucocytes in the formation of thrombi.

These men

demonstrated that it was an accumulation of these particular elements which were referred to as white
thrombi.

But the so-called red and the mixed, or lami-

nated, intravascular clots have also been well known
and it is the interrelationship of these three types of
thrombi which this section attempts to unfold.
Close examination of a completely formed venous
thrombus, as shown by Aschoff (6) reveals a very regular
relationship between the colors .

The first portion is

white, forms the smallest part of the entire structure,
and is known by the German

11

Kopfteil 11 •

Attached to this

and serving as the next link in the fully-formed thrombus
is the "Halsteil", mixed in color .

And finally, extend-

ing perhaps for many centimeters and forming the bulk
of the structure, is the deep red porti on, t he
"Schwanzteil" .

Additional study has revealed (6) that

-sa red thrombus can form only where there has been a
more or less complete obstruction of the lumen of the
vessel by the white thrombus; very long white thrombi
may form along the wall of a vessel only when the bloodstream continues to flow past this point .

Thus it may

be inferred that, in at least the majority of autochthonous thrombi in man, the white thrombus is the determining and peculiar factor in the whole process and
that the red thrombus is accidental; it may, but does
not necessarily, occur.
Delicate ripple-like ridges, the so-called Zahn 1 s
markings, appear on the surface of the "Kopf 11 and
"Halsteil" and extend only a short distance into the
11

Schwanzteil 11 •

The explanation for these markings

becomes evident upon microscopic study of the thrombus.
Examination of a longitudinal section through the first
two portions of the clot reveals a definite frameworkskeleton consisting of numerous delicate beams in rings
which form above the fine ridges seen on the surface.
In the early stages of development the framework is made
up of a finely granular mass consisting of platelets.
iach -beam thus constructed is surrounded by a borde! of
polymorphonuclear leucocytes and is thus well separated

fro m the ma ss of red blood which fills the interstices.

-9There is a definite relationship among the beams of the
framework; they follow one another at fairly regular
intervals and build up grouplike systems.

Also secondary

beams are seen in these groups extending either upward
or downward from the primary beam of the fr~nework.

As

they approach the pointed outer extremity of the "Kopfteil", the beams become broader and the furrows between
disappear until finally the beams unite into a single
mass to form the pure white outer surface of the "Kopfteil".

It should be emphasized at this point that very

little fibrin appears in this entire structure; where
found, it assumes a definite pattern.

Just where the

red blood comes in contact with the framework of platelets threads of fibrin shoot out, subsequently penetrating more and more of the bloo d itself.
The question arises whether the thrombus takes
origin in the flowing or stagnant bloodstream .
Zahn (132), in contending that the thrombotic masses
were composed of white cel l s , pointed out that the
flowing stream was necessary for deposition of these
particular blood-elements at a single site.

But when

others (49,36) laid stress upon the platelet origin of
thrombi the problem once more came forth.

If platelets

were to be considered merly disintegration products of

-10-

white or of red corpuscles, as many observers claimed,
then a thrombus could well have formed from the disintegration of these blood-elements which had died because
of the stoppage of the stream.

If, on the other hand,

platelets were assumed to be independent elements, as
affirmed by some students, the importance of a flowing
bloodstream becomes obvious.

However, since the demon-

stration by Bizzozero (16) that the platelets do represent a third element of mammalian blood, it can be
concluded that the accumulations of these blood-platelets
in thrombosis can occur only when the blood is circulating.
Upon conclusion, therefore, that the thrombus formed
of platelets has its origin in the moving bloodstream,
a second question suggests itself:

How do platelets

build themselves into the definite framework-pattern
above described?

Ferge (42), in studying serial sections

and constructing models of human thrombi, determined that
the platelets do not form beams running in circles, but
do form a system of lamellae, more or less parallel and
arranged o~ the vessel wall one behind another.

Most

of these run obliquely or transversely to the long axis
of the vessel.

These lamellae, by growing outward from

the vessel wall, become bent in the direction of the

-11-

blood-flow by the coursing of the blood through them.
The mechanics of the formation of this system is comparable to that of the production of ripple-like patterns
in the sand of the seashore by the ebbing tide--the sand
is pushed up into a small ridge by tne advancing water
until this obstacle is overcome by the strength of the
flow and the water's edge advances to create new ripples
farther on.

The lamellar system on the vessel wall is

built up in a similar fashion by the sand-like multitudes of blood-platelets.
one respect:

But this analogy fails in

on the one hand, pre-existing masses are

formed into particular designs by the undulating flow;
on the other hand, the solid elements are taken from
the flowing bloodstream and laid down in a definite
lamellar pattern .

Aschoff (6) demonstrated exactly

similar deposits formed from a given solid material in
running water when the velocity of the flow was reduced
sufficiently by the introduction of a dam~

He found

that no transformation of the precipitated particles
occurred, but that these particles were laid down in
this particular pattern from the first.

As long as the

blood continues to flow through the system of lamellae,
new masses of platele t s are deposited on their surfaces
so that new systems are always being built up behind the

-12first one.

The first-formed system naturally exhibits

the most rapid growth, so that a time finally comes
when the openings in the lamellae of this portion are
so narrowed that the bloodflow becomes slower and slower
and final l y stops altogether.

At this point the building

of the primary thrombus, or "Kopfteil 11 is complete
since, the blood having come to a standstill, no new
platelets can be carried past and growth is impossible .
Just before tne complete cessation of the bloodflow
and when the stream is divided into numerous parts by
the lamellar system, a separation of white and red
corpuscles occurs.

Eberth and Schimmelbusch (36) have

shown that when the bloodstream is slowed t ne white
corpuscles, which are of lighter specific gravity than
t ne others, tend to le ave the axial current and flow in
the peripheral parts of the stream.

These peripheralized

corpuscles, then, upon contact with the lamellar walls
in their passage through their respective narrowed
channels, adhere to the framework--hence the explanation
for t he leucocytic zones surrounding the platelet-beams.
What follows in the peripher al part of the vessel-i.e., from the region of the white thrombus to the point

of entrance of the next anastomosing vessel--where complete stasis has occurred is of i mportance in the

-13enlargement of the thrombus.

The blood, so trapped, has

been shown to undergo a complete coagulation.
11

Thus the

Schwanzteil 11 of the thrombus, usually of some length

and red in color, is formed.

Microscopically, this part

shows no definite framework of platelets but consists
of an irregularly arranged mass of red and white corpuscles, platelets, and fibrin.

Though there is sometimes

the attempt of the white cells and platelets to form
into masses, no such definite lamellar form is taken as
is seen in the "Kopfteil".

The fibrin masses sometimes

appear as striped thickenings running in definite directions; this appearance may be accounted for, perhaps,
by the fact that this particular stagnant column of
blood is still connected, manometer-fashion, to the pulsating flow of the rest of the vascular system.

And thus

the difference between the "Kopfteil" and "Scnwanzteil"
of the autochthonous thrombus has been demonstrated--the
formation of the one part in the flowing stream, the
other in the stagnant pool.

While the work of Shio~

noya (105), Best {14), and Bauer (10) conflict with the
theory of Aschoff as to the direction of growtn of the
clot, there is no essential refutation of its composition or of t he relative position

of its components.

-14The physical nature of this phenomenon becomes
clearer when the bloodstream is compared to a river in
which floats innumerable small particles of different
specific gravities:

a sudden increase in the depth or

width of the stream in question produces a slowing of
the constituent molecules of water; it is at such sites
that sandbars are formed.

It is concluded that there

is, therefore, an optim~~ velocity which will bring
about a local aggregation of particles; neither by a
rapidly flowing current nor by a complete cessation of
the flow can such a heaping up be brought about.

Thus

it is that when the blood within the vessel is caused
to flow slowly, or at least differently, a local piling
up of blood-elements occurs.

A uniform retardation of

the current is no t particularly the i mportant factor,
but rather tne inequality of the local conditions which
predisposes to this deposit.

Aschoff (6) found proof

of this fact by the insertion of a dam to produce countercurrents and eddies in his experimental stream.

These

findings are all suggestive only; it is more difficult
to determine exactly what is occurring within the bloodstream.

Yet these facts do lead to a better under-

standing of the importance of the s l owing stream in the
genesis of white thrombi.

-15But what of the stasis in the formation of the red
portion of the clot?

Microscopic examination of this

latter part reveals that in the neighborhood of the
11

Kopfteil 11 it is dense while peripherally it becomes

more and more spongy.

The denser portion is richer in

fibrin and leucocytes and even has suggestions of lamellae within; the softer parts approach more closely
the appearance of normal blood.

Also, as already

mentioned, coagulation phenomena have been observed to
take place in the blood lying within the skeletal framework of the white thrombus.

A study of this localization

of the fibrin suggests tne interaction between the
fibrin ferment set free by the death of the platelets
and the stationary blood-plasma around them.

Undoubtedly

considerable amounts of this "ferment" is released from
the platelets; it then acts locally to coagulate the
blood bathing the framework of the

11

Kopfteil 11 and slowly

diffuses caudally into the stagnating blood-column.

The

crystallizing out of fibrin which results from this
phenomenon and which thus produces the red tnrombus as
above described is known as the process of coagulation;
it is fully discussed below.

A chemical, as well as a

mechanical, basis may therefore be ascribed to .the formation of intravascular clots.

-16This consideration of the physiological pathology
of the human thrombus serves to emphasize the importance
and co-existence of the two fundamental phenomena, agglutination and coagulation.

It is imperative , therefore,

that each of these processes, though inseparably basic
in the development of the intravital clot, be considered
individually.

III.

COAGULATION MECHANISM
General Observations

Coagulation is that mechanism whereby the fluid
portion of the blood becomes a solid by the conversion
of a soluble protein, fibrinogen, into a colloidal ge l,
fibrin.

This transformation has long been a matter of

concern and, complex though it may be, is consequently
one of the best understood reactions of blood and, accordingly, has been overly emphasized in its relationship
to the genesis of thrombi.

Blood clotting has been suc-

cessfully studied in vitro where the conditions of coagulation can be controlled.

When blood is allowed to

stand in a test tube for five or six minutes, .it loses
its fluidity and sets into a jelly (15).

Inversion of

the tube no longer causes the blood to spill; it has
become a coagulated mass .

Micros copic examination of

this clot reveals a meshwork of many fine fibrils, among
which are entrapped numerous white and red cells and
fragments of platelets, a structure resembling closely
the

11

Schwanzteil" or red thrombus.

-lSThe concept of coagulation as a solidification of
the whole blood was held during t he time of Hippocrates
and Galen.

The first evidence that probably only one

substance of the blood was responsible for the visible
phenomenon of clotting was made in 1666 by Malpighi (71)
who observed the mass of white strands which remained
after a bloodclot was washed.

1770

Hewson (50) showed in

that a solid separated from the blood during coag-

ulation and that cellular elements did not participate
in this process.

He also demonstrated that neutral

salts such as sodium sulfate inhibited clotting.

The

idea that blood contained an a gent which was responsible
for the clotting of fibrinogen was introduced by
Buchanan (20) in lS35.

It was Schmidt {9S) who vital-

ized 'the sub ject of coagulation by postulating the
interaction of various factors of the plasma in the
transformation of fibrinogen to insoluble fibrin.

He

included the important hypothesis t hat the thromb in is
formed from a precursor, prothrombin, which is activated
by zymoplastic substances, lipoid i n nature, thus
putting the entire mechanism on the basis we know it
today.

Newer knowledge on calcium and its role in blood

coagulation led Morawitz (79) and Fuld and Spiro (48)
to reformulate Schmidt's hypothesis.

They stated that

-19thrombin was perhaps formed as tne result of the activation of prothrombin by thromboplastin in the presence
of ionic calcium.

This has become the classical theory

which has held up under the scrutiny of many observers.
Coagulation has too often been regarded solely in
its function of hemostasis; its other roles in the total
physiological scheme of the organism have received but
little emphasis.

The amount of fibrinogen, for example,

in the circulating blood is five times that needed for

the effective utilization in hemostasis and may increase
over three-fold in certain_ infectious diseases, even
though infection is rarely or never complicated by
bleeding.

This must mean that fibrinogen serves

functions other than mere control of hemorrhage.

The

coagulation mechanism must come into play wherever there
is a need for fibrin.

General recognition of the

broader aspects of this mechanism will place it in its
rightful position of importance.
Irrespective of the consideration of other possible
functions of coagulation, its role in hemostasis has
been overrated, especially in ascribing the genesis of

t hromb osis to a primary clotting process.

Quick (90)

calls attention to the fact that the organism which so
assiduously protects its vital mechanism is not apt to

-20-

entrust the full task of protection against hemorrhage
to one isolated reaction and that it is more probable
that coagulation is only one part of the hemostatic
mechanism .

A survey of the evolution of the hemostatic

process can best be used to prove this point .

In the

very primitive forms no distinct coagulation occurs (90).
The high viscosity of the blood and the subatmospheric
blood pressure in these organisms serve the necessary
function of prevention of hemorrhage.

In many of the

arthropods is observed tne first specific .hemostatic
mechanism (63) which consists of an agglutination of
the primitive blood cells.

With further evolution and

tne development of the more complex organism with a
higher blood pressure, an additional protection against
hemorrnage is required.

It should be emphasized that

tne new mechanism wnich developed, that of conversion
of a soluble plasma constituent into an insoluble one,
appeared only as an addition to the ·previous mechanism,
not as a repl acement.

The Crustacea are the first

animals phylogenetically which possess such a mechanism (72).

Though the exact development of coagulation

remains unknown, one can appreciate the complexity of
the problems which arose in the institution of the new
process of plasma coagulation.

With the appearance of

-21-

fibrino gen in the blood, a specific substance had to be
applied which could act on this soluble agent to precipitate it.

But this new enzyme obviously could not

be put into the blood in its active form.

The inert

form as adopted is known as prothromb in.

Furthermore,

a need arises for a substance capable of activating prothrombin, and this material likewise must occur free in
the blood but in an inactive form.

This problem was

solved by incorporating this substance into a blood
cell, the same one which is important in the agglutination process, which in the human is the platelet.
Thus the processes of agglutinati on and coagulation are
closely linked, for in the latter the cells disintegrate
and liberate thromboplastin thereby initiating the
fibrinogen coagulation.
Blood Constituents
The classical theory of the coagulation of blood,
as mentioned above, may be expressed by t wo simple
formulations:
Prothrombin + calcium + thromboplastin ---+ thrombin;
Thrombin + fibrinogen --+ fibr i n:
This explanation of the phenomenon of precipitation of
fibrin has remained the most satisfactory hypothesis

-22-

and is today accepted by nearly all investigators.
Following is a consideration of the various factors
present, or formed, in the bloodstream which are important in the mechanism of coagulation.
Thrombin
The action of thrombin in converting soluble fibrinogen into insoluble fibrin can be considered the
most fundamental reaction in the coagulation of the
blood.

Since fibrinogen is the passive agent in this

reacti on, thrombin must be regarded as the central substance in the mechanism of coagulation.
The determination of the chemical composition of
thrombin has met with difficulty because of the lack of
a pure preparation.

It is generally accepted to be a

protein containing sulfur probably present in the SH
form; there is no phosphorus in the molecule (cited by
Quick (90)).

Seegers (99) believes this substance to

be composed of about five per cent carbohydrate.

His

studies of the physical properties of thrombin indicate
that it is very soluble in water and in physiological
saline solution and that it is precip itated in the pH
range of 5.1 to 3.4.

Pure thrombi n has a marked sta-

bility but is destroyed by strong acids and alkalies
and by heat (60° C. for 30 minutes).

-23The exact nature of the thrombin-mechanism has been
questioned by many investigators; the enzyme theory of
action is gaining favor.

Eagle (34) showed that a puri-

fied preparation of thrombin was able to coagulate over
two hundred times its own weight of fibrinogen.
Seeger s (99) produced even more striking results with
his more highly purified substance.

The enzyme theory

is further strengthened by the observation that the addition of a very small amount of thrombin to plasma or
to a fibrino gen solution brings about . successive crops
of fibrin over a considerable period of time; this suggests a continuous reliberation and reuse of thrombin.
Though the exact alteration of the fibrinogen molecule
brought about by the thrombin is unknown, it is recognized that a specific change does occur whereby an
irreversible fibrillar gel results.

Thrombin apparently

has no proteolytic properties (99) and so this transformation is not mediated by the splitting off of nitrogen.
Lyons (6S) advances the theory that vitamin K is a
functional part of the thrombin molecule, that the clotting of fibrinogen by thrombin requires two stages--the
liberation of blocked -thiol groups in fibrinogen by
one component of thrombin and an oxidation, probably by
a naphthoquin6ne complex in thrombin , converting

-24pr9tein-SH to protein-S-S-protein (fibrin).

Of interest

is the work of Eagle (32) on the properties of certain
snake venoms which also coagulate fibrinogen enzymatically.

The relationship of these venoms to thrombin

is unknown.
Since the coagulation rate is a function of the
concentration of thrombin, the latter can be determined
directly by the clotting time.

This has been demon-

strated by Quick (90) who used progressive dilutions of
a standard thrombin solution and measured the respective
coagulation rates of plasma.

A curve plotted on the

data obtained is hyperbolic in character indicating that
with high concentrations of thrombin coagulation is instantaneous and with increasing _dilutions the coagulation
time approacnes infinity.

There is very little change

in the coagulation time above a twenty per cent concentration of thrombin but a very rapid prolongation below
that point.

This means that at this particular level a

minute change in the concentration of thrombin has a
marked effect on the clotting time.

It might then be

assumed that the diluting effect of the circulating
blood on the thrombin liberated at any given point is
an important factor in the prevention of excessive
thrombosis.

This explains the fact that intravascular

-25fibrin-precipitation tends to be associated with a
stagnant circulation.
Prothrombin
Protnrombin is the precursor of thrombin; it is
found in the plasma, lymph, and probably the intercellular fluid.

That this substance is formed in the liver

has been shown by many investigators (3,67,108,122); it
probably originates in the hepatic parenchyma (94).

Its

produc ti on is readily interfered with by disturbances
of liver function {lOS,122).

The discovery of vitamin K

in connection with hemorrhagic chick disease has supplied
an additional fact concerning the production of prothrombin in the body.

It has been firmly established

that this vitamin supplies a chemical group which is
essential for the synthesis of prothrombin (90).

The

function of this chemical group is unknown but it is
probably not an integral part of protnrombin because,
as shown by Lyons (68), large amounts of dried prothrombin mixed with food failed to relieve the hemorrhagic lesions in K-avitaminous chicks.

This vitamin

is fat soluble, is produced by intestinal bacteria, and
is deficient in man when intestinal absorption is impaired , particularly when there is interference with

-26the circulation of bile.

Vitamin K occurs naturally in

alfalfa, spinach, and many other foodstuffs and in
certain bacteria (19).
The fate of prothrombin under normal physiological
conditions is not known.

Andrus, Lord, and Kauer (2)

nave shown in their experiments in dogs that there is a
decrease in the plasma prothrombin level in its passage
through the lungs.

In a quantitative study of this

substance, Warner, Brinkhous, and Smith (123) found in
normal dog plasma sufficient prothrombin to form more
than two hundred times the concentration of thrombin
necessary to clot fibrinogen within a few seconds.

They

also recorded that prothrombin levels are remarkably
consistent even in face of large hemorrhages or drastic
changes in the diet of do gs as well as in cases of
sterile abscess and distemper.
The exact knowl edge of the properties of prothrombin
has awaited tne recent h i gh degree of purification of
t he substance as accomplished by Seegers (99).

His

product is very soluble in water, is easily precipitated
by the alkaline earth metals, and is flocculated at
pH 5.6.

It is a euglobulin (37) and has been placed in

plasma group II + III of Cohn ( 25) in his work on
fractionation of blood proteins .

Prothrombin is

-27inactivated by heat at about the same temperatures as
is t hromb in; it is also likewise destroye d by strong
acids and alkalies.

It is a protein containing about

f our per cent carbohydrate; its activity supposedly
resides in its free alpha-amino groups.

Certain chemi-

cals includi ng insoluble hydroxides and silicates of
aluminum and magnesium (37) as well as Berkefeld
filters (90) will absorb prothrombin.
Numerous theories have been advanced regarding the
mecnanism of conversion of prothrombin to thrombin in
the process of clotting.

Only the theory of Morawitz

(79)

and of Fuld and Spiro (4-S), which states that prothrombin
is activated by thrombokinase in the presence of calcium,
has consistent l y held ground.

It had been generally

acce pted by those who subscribed to the classical theory
that prothrombin was converted to thrombin molecule for
molecul e.

~agle (33) demonstrated experimentally the

accuracy of this contention by showing that a fixed
amount of prothrom bin yielded a constant amount of
t hrombin irrespective of t he excess of platelet suspension or the amount of calci um .

The roles played by

t h ese latter two agents in the normal mechanism of coagulation are ful l y d iscussed below, but their relationship
to the changes i n the prothrombin molecule are best
mentioned at this point.

-2$-

Calcium, until recently, was considered to have
only a passive part in the production of thrombin.

The

action of thromboplastin, however, as found in tissue
extracts and in platelets, has been open to question-whether enzymatic or chemical.

The enzymatic concept

is the oldest, having been proposed by Morawitz in his
early studies of the indispensability of thrombokinase
in coagulation.

iagle (32) recentl y revived this theory

in his demonstration that trypsin, and trypsin-simulating
snake venoms, have the capacity to convert prothrombin
to thrombin.

Though it is not known with certainty

whether these proteolytic enzymes react with prothrombin
directly or whether they liberate calcium and thromboplastin, it has been assumed that t he action is enzymatic and ·, by inference, tnat the calcium-platelet
mixture may contain a similar enzyme.

Strong support

for t he chemical theory of t hro mboplastin-prothrombin
interaction comes fro m the experiments of Mertz, Seegers,
and Smith

(77).

They observed that when a fixed quanti-

ty of protnrombin was mixed with controlled increments
of thromboplastin, the amount of thrombin formed was
direct l y proportional to the quantity of thromboplastin
until an excess of the latter was present, after which
a maximum cons t ant quantity was produced.

Thus the fact

-29that thromboplastin is quantitatively consumed in the
reaction is strong support of the chemical hypothesis.
Quick (90) suggests that . the thromboplastin may furnish
to protnrombin a comparatively small radical to replace
.the calcium which he says has been removed (see below).
In the recent clinical studies of diseases displaying a hemorrhagic or thrombotic diathesis a great
deal of emphasis nas been placed upon the importance of
the prothrombin levels of the plasma.

Since the total

clotting time is a measure of the prothrombin-conversion
time plus tne time required for the interaction of
tnrombin and fibrin, several methods have come forth
for more direct determination of the prothrombin time.
These several tests are based on tne conclusion that
the rate of thrombin formation is directly proportion~l
to the prothrombin concentration

(77).

Most widely used

clinically today is the test developed by Quick (15).
It consists briefly of addition to oxalated plasma of
optimal amounts of thromboplastin and calcium, followed
by a direct measurement of the clotting time.

Pro-

thrombin is the only variable in this reaction; on this
supposition the validity of the test rests.

The results

of this test are compared to a normal of 100; a pro\

longed prothrombin time indicates a decrease in the

-30concentration of this substance and is expressed in
percentage less than 100; a decreased prothrombin time
means an increase in protnrombin-concentration and is
recorded in percentage greater than 100.

Recent modi-

fications of this procedure calls for running tests on
whole and diluted (12¾) plasma .

Shapiro, Sherwin,

Redish, and Campbell (103) assume that dilution renders
the normally circulating anticoagulants ineffective and
that minor changes in the prothrombin time are more
easily discernible; they also stress the importance of
the value of the difference between whole and diluted
plasma readings.
To interpret the significance of the various levels
of prothrombin as determined by the procedure above
described, Quick (90) plotted a curve correlating the
clotting time (when excess thromboplastin is present)
and the concentration of prothrombin.

He found that the

clotting time is little influenced until the concentration is reduced to about 20 per cent (S9).

The range

tnen from 20 to 100 per cent can be considered the
margin of safety, while that part of the curve below
20 per cent may be designated as the hemorrhagic zone.
At this level very slight changes in the prothrombin
concentration may have profound effects upon the

-31bleeding tendency.

These facts explain why a patient's

protnrombin may be reduced 50 per cent witn no ill effects whereas minor changes in the individual with a
previously low level may produce dire consequences.
Thrombo12lastin
Thromboplastin, variously known as thrombokinase
and fibrin ferment, is a complex substance present in
platelets and in various tissue cells and is essential
for the conversion of protnrombin to thrombin.

This

substance is very widely distributed in the body, found
in most of the tissue cells witn particularly rich supplies in the brain, lung, thymus and testes (90).

But

of paramount importance in coagulation is the thromboplastin content of the platelets.

This substance is

intracellular in contrast to prothrombin which is always
extracellular.
Because thromboplastin has not been isolated and
purified, much of the information concerning its cnemical and physical properties is uncertain.

The most

active preparation available today is an aqueous emulsion prepared from rabbit brain.

This material forms

a colloidal ratner than a true solution; it does not
pass through a semi-permeable membrane.
sistant to heat than is prothrombin.

It is more re-

Tne chemical

-32constitution of thromboplastin has been long questioned;
most investigators now consider it to be a lipid or
lipo-protein, the main portion of which is a cephalinlike compound.
Despite the many studies concerning the coagula~
bility of the blood, it has always been recognized that
circulating blood normal l y remains fluid.

Prothrombin,

fibrino gen, and calcium occur free in high concentration
in the bloodstream.

Free or available thromboplastin,

on the other hand, is absent except perhaps in insignificant quantities, as is indicated by the work of Jacques
et al (56).

Quick (90) has shown that when very high

dilutions of thromboplastin are added to chicken plasma,
there is a marked change in the clotting time in the
presence of very minute changes in the concentration of
thromb oplastin.

Increasing this agent only to a certain

amount will shorten the clotting time; thereafter no
further change occurs regardless of an excess of thromboplastin.

It is concluded that the amount of thrombo-

plastin needed for normal coagulation must be exceedingly
small.

The exact role of theomboplastin in the con-

version of prothrombin has been discussed above.
With the very wide and ample distribution of
thromboplastin throughout the body it might be asswned

-33that herein lies a precautionary mechanism against internal hemorrhage.

Quick (90) questions the efficacy

of such action and suggests that the amount of thromboplastin furnished by the severed tissue in the case of
an external wound is not of significant value.

In all

probability, the quantities of this substance as utilzed in coagulation is furnished by the platelets.

The

thromboplastin present in the tissue probably subserves
other physiological mechanisms wherein deposits of
fibrin are required by the body.
The blood platelet, then, is apparently the most
fundamental factor in hemostasis as it is known to participate in all the mechanisms utilized by the body to
control the loss of blood--agglutination (for which evidence is presented in a later section of this paper) and
coagulation.

In its la:tter capacity the platelet

functions in three ways:

it furnisnes thromboplastin;

it assists in firmly attaching the fibrin strands to
the vessel wall; and it is responsible for clot retraction.
In 1$$2 when Bizzozero

(16) first described

platelets as a third element of mammalian blood, he suggested that their disintegration mi ght liberate a coagulative ferment which initiated coagulation. Osler (34)
recognized that platelets disintegrate in shed blood and

-34that this process is slowed by cold.

The exact process

of the disintegration of platelets has been observed by
Tait and Burke (116):

11

During the first two or three

minutes the (platelets) undergo progressive expansion
while clear blebs or spherules begin to appear round
their margin.

Then the platelets suddenly disintegrate

and the spherules travel swiftly outward into the surrounding plasma, diminishing in size down to eventual
extinction as they progress.

In the path followed by

the spherule a filament of fibrin appears."

This

statement furnishes direct proof of the role of platelets
in blood clotting.
Further evidence of the importance of platelets has
been shown by many investigators who sought to delay or
prevent coagulation by the removal of platelets or their
products from shed blood.

However, mammalian platelets

are usually so labile that, despite the greatest precautionary measures, any attempt to remove them from the
plasma produces enough disintegration to cause rapid
coagulation.

Jaques et al (56) recently succeeded, by

the use of very special techniques and employing siliconecoated glassware and needles, in preserving the platelets
and .preventing coagulation up to half an hour.
figure is a significant increase over the use of

This

-35unprotected glass containers.

They found that contami-

nation of the blood samples even with very minute amounts
of substances from damaged tissue will cause a rapid
clotting of plasma .

The stability of platelets depends

upon an intrinsic and an extrinsic factor.

In the normal

blood of any one species the former may be distegarded
in co inparative studies.

Extrinsically the stability of

the platelet is markedly reduced by an increase in
carbon dioxide tension to which the blood may be exposed, by the presence of a high concentration of adrenalin, and by recalcification of a previously decalcified
sample of blood (90).
The other two functions of platelets which are important in hemostasis need only brief mention at this
point.

The increased gluing effect of these elements

in producing a stronger adhesion between fibrin and the
vessel wall is im portant in prevention of the washing
out of the clot from the severed vessel.

The clot re-

traction mechanism serves its purpose in hemostasis in
drawing the torn edges of a vessel together following
injury and early clot formation; this function is tested
clinically by clot retraction and bleeding times.
The studies of J.H.Wright (131) showed the origin
of platelets to be detached portions of megakaryocytes

-36found in the bone marrow and in the spleen.

Little is

known as to the regulatory mechanism that maintains a
relatively constant number of platelets in the circulating blood.

It has been suggested that the oxygen

tension of the blood is the primary factor.

The de-

struction of these element·s also presents a problem; it
is most generally accepted that they are removed by the
spleen but the controlling forces are unknown .
Ca1Ci1!!!1,

Calcium exists in the blood in two forms, free and
bound.

Most of the non-ionized calciu~ is probably

bound to the serum proteins; this constitutes roughly
about half of the total calcium..

Since the early work

on blood when Arthus and Pages (5) showed that the removal of calcium prevented coagulation, it has been
generally accepted that the ionizable calcium is essential for the conversion of prothrombin to thrombin
but is not needed for the activity of thrombin.
Certain problems concerning this mechanism had,
however, gone unanswered until recently when Quick (90)
advanced a slignt change in this theory.

Re suggests

that there is in the circulating bloodstream a weakly
ionized compound composed of calcium and prothrombin
and that it is the fact that ionization here is weak

-37that the discrepancies in the theory have arisen.

He

would therefore suggest a modification of the first
formulation of the classical theory of coagulation to
read:
ProthrombinCa + thromboplastin- thrombin
Further study of this hypothesis will have to be made
before its acceptance or rejection.
Fibrinogen
Fibrinogen, one of the plasma proteins, possesses
some unique characteristics which differentiate it
sharply from the albumin and globulin fractions.

Its

concentration in normal blood is found between 200 and
600 milligrams per 100 milliliters.

By the action of

thrombin it is converted from a colloidal sol to a gel
which shows microscopically a crystalline-like structure.
In contrast to the other plasma proteins which are noted
for their stability, it is very labile, being markedly
affected by various stimuli.
The chemical and physical studies on fibrinogen
have not been too satisfactory though they have given
some knowledge of the characteristics of this substance.
Bergmann and Niemann (12) have analyzed fibrin and demonstrated the presence of nine amino acids including
cystine.

Quick (90) suggests that the cysteine or

-3Scystine in the molecule is perhaps of direct importance
in the actual coagulation of fibrinogen.

Lyons (6g)

believes the i mpo~tant step in conversion of fibrinogen
to fibrin lies in the change of the -SH (as found in
cysteine) to the R-S-S-R (as found in cystine and in
fibrin).

Fibrinogen is present in Group I of the

fractionation products of plasma by Cohn (25); on the
basis of solubility it is classified as a globulin .
lts molecular weight has been estimated as 69,300 (12)
wnich would make it larger than the molecule of serum
albumin.

It is precipitated in an acid medium and also

by a solution of half saturated sodium chloride.

Howell (52) observed that fibrinogen, when acted upon
by thrombin, was converted directly into crystal-like
needles of fibrin.

Some investigators have suggested

that a fibrinogen-thrombin complex is formed preceding
the formation of fibrin; they choose to call this substance profibrin.

Its importance in coagulation has not

yet been established though its existence would serve to
support one of the theories of agglutination (see below).
The site of synthesis of fibrinogen in the body 1s
commonly accepted to be in the liver.

Drury and

McMaster (31) fol l owed the fibrino gen levels in hepatectomized rabbits and found a transient rise immediately

-39following hepatectomy but a gradual decline thereafter
as the existing fibrin was utilized by the body.

They

suggest that there may be a fibrin reserve in the body,
probably in the lymph, but that the liver is the most
important, if not the only, site of formation.

Jones

and Smith (57), working with dogs, reached the same conclusions upon the experimental evidence that the level
of blood fibrinogen dropped
hours following hepatectomy.

20-5o% in twelve to twenty
The effect of acute

chloroform poisoning on the liver is sufficient to reduce both plasma fibrinogen and prothrombin though the
former is the least affected, according to Smith, Warner, and Brinkhous (108).

Quick (90), on the otner

hand, is very wary about accepting as an established
fact that fibrinogen is synthesized by the liver even
though he recognizes that the liver plays an important
role in the metabolism of this substance.
The lability of the fibrin-fraction of plasma was
emphasized by Smith, Belt, and Whipple (107) who recognized that this portion regenerated within twenty-four
hours after its washing out by plasma d·e pletion; the
other serum proteins required several days for their
re adjustment.

These findings suggested that the mecha-

nism of production of the former must be different from

-40that of the latter and that fi brin is constantly being
utilized in the body's economy.

The most important

functio n s of fi brinogen are recognized by Quick
as:

{90)

its tole in hemostasis by the formati on of an e-

lastic, adhesive, retractable clot; its possible part
in agglutination and perh aps pnagocytosis by the ability
to form a film about particles; its use as one of the
defensive mechanisms of the body against infections; and
its appearance as a factor in wound repair.
Whi pple

Foster and

(44,45,46) in a series of studies attempted to

determine the influences of various factors upon fibrin
values.

Their method of measuring fibrin might perhaps

be open to question~

They found, however, that the

fibrin levels are increased by the production of a low
fibrino gen c oncentration, by hi gh protein feeding, by
the stimul a tio n of the ions present i n Locke's solution
i n jected intravenous l y, by hemorrhage, by small doses
of liver poisons, and particularly by any type of tissue
injury or inflammati on.

Fi brin values are not changed

by die t s high in carbonydrate and fat and by great
fluctuations in the blood pressure.

The level of the

circulating fibrin may even be reduced by ingestion o·f
quantities of th yroid sufficient to produce a loss of
weight and by large doses of liver toxins.

-41Since fibrin clots serve only for temporary emergencies and are not permanently employed within the
body, it might reasonably be assumed that the organism
possesses an agent that dissolves fibrin.

Such a

substance was first described in 1g90 by deMarbaix and
Denys (73); a great deal of investigation on fibrinolysin
has followed.

How does this agent serve the body?

It

probably aids in canalization of thrombi and may function
in relation to the agglutination mechanism if the fibrincoating of the elements be recognized as an important
factor.

That deposits of blood. within the tissues are

known to liquefy and. that the fibrin of lobar pneumonia
may undergo rapid dissolution lend further support to
the utility of a physiological fibrinolysin.
Anticoagulants
It is nothing less than remarkable that although
all the elements concerned in the process of coagulation-protnrombin, calcium, thromboplastin, and fibrinogen-are present in the normally circulating blood tnere is
no disturbance of the fluidity of this substance.

And

yet, these agents become active when a need for them
arises.

Tnis very fact has disturbed many investigators

to speculate and hypot nesize upon the principles and
mechanism of anticoagulation .

Many substances have been

-4-2discovered wnich would prevent the blood from clotting
in vitro; their importance must not be underestimated
as they have become invaluable aids in the study of the
normal clotting mechanisms.
What forces, then, are responsible for the maintenance of fluidity within the vessels?

It was pointed

out above tnat the thromboplastin is locked up within
the platelet and, since . the integrity of tnese cells is
undisturbed in the normal circulation, no thrombin is
formed.

Therefore, no anticoagulant has to be postu-

lated, and, as a matter of fact, no convincing evidence
for such an agent in the bloodstream has been forthcoming (90).

Even if thrombin should form witnin the

circulatory system, the body has two mechanisms whereby
it can protect itself:

by diluting the thrombin in the

course of circulation and by neutralizing it with the
natural antithrombin, called by Quick (91) albuminX.
One other factor has to be borne in mind--that to maintain the integrity of the platelets and to sustain an
uninterrupted, almost frictionless, bloodflow the endothelial linings of the blood vessels must be intact (106).
Thus we might expect a disturbance in the normal fluidity of the blood when the endotnelium is damaged;
these lining s play a passive, but extremely important
role, in preventing coagulation.

-43Since there are only five factors whicn participate
in the coagulation reaction, there should be theoretically five types of anticoagulants--antiprothrombins,
decalcifying agents, antithromboplastins, fibrinogen
antagonists, and antithrombins .

For the most part, the

various substances which have been found to act in these
devious capacities have only been useful in studies of
tne blood in vitro.

However, two physiological agents,

antitnrombin and heparin, have recently been stressed
for their important part in relation to the mechanism
of coagulation.
An antithrombin may be defined as a substance which
binds or neutralizes thrombin; an anticoagulant is a
substance whose affinity for thrombin exceeds tnat of
fibrino gen .

Quick (91) studied the inactivation of

tnromb in in serum quantitatively and found that its
antithrombic activity resides in the albumin fraction;
he concluded that the albumin or so~e closely associated
substance is the normal antithrombin of the blood .
named tnis fraction albuminX .

He

Quick explains the in-

activation of thromb in by asserting tnat it unites with
its s ub strate, fibrino gen, as an intermediary step in
tne formati on of fibrin .

But once this transformation

has occurred, thrombin is split off and is free to react

-44again.

AlbuminX also possesses a structure with which

thrombin can unite, but its affinity for thrombin is
much less than that of fibrinogen.

Consequently throm-

bin only reacts with the albumin after all the fibrinogen has been coagulated.

This theory is consistent

with the statement by Wilson {125) that the antithrombic
activity of the blood has been shown to decrease markedly during the process of clotting.

Quick (91) further

states that it is improbable that an increase in the
normal antithrombin factor could exert any significant
inhibitory action on coagulation.
Howell and Holt (53) in 1918 described an anticoagulant which, because of its high concentration in
the liver, they named heparin .

Today its cheapest com-

mercial source is beef lung and it is purified by its
crystallization with barium.

Chemically it is probably

a mucoitinpolysulfuric acid, containing glucosamine and
uronic acid.

It has the property of combining and re-

acting with various proteins and it is non-toxic if
highly purified , (13).

Jorpes, Holmgren, and Wilander {58)

found that heparin stains metachromatically with toluidine blue and that the mast cells - of ihrlich distributed
throughout the body display the same reaction.

They

postulated that these cells are responsible for the

-45synthesis of this substance and demonstrated a very good
correlation between the heparin content of various
tissues and the number of mast cells.

These cells are

found throughout the body, most abundantly in richly
vascularized connective tissue.

After intravenous in-

jection, heparin disappears rapidly from the bloodstream.
Jaques

(55) obtained as enzyme, heparinase, from rabbit

liver which destroys this substance.

Heparin is liber-

ated in peptone and anaphylactic shock and so renders
the blood incoaguable (13,35,123).
Ziff and Chargaff (133) found that to exert its
anticoagulant action heparin requires an additional
factor known to be present in blood, plasma, and serum;
this activity seems to reside in the most soluble
fraction of serum albumin.
conclusion.

Quick (91) concurs with this

The normal antithrombin of blood, as shown

above, is albumin or some closely associated constituent.
Since fibrino gen displays a greater affinity for thrombin
than does albumin, no appreciable neutralization or inactivation of thrombin occurs until all of the fibrinogen is converted to fibrin.

However, upon the addition

of heparin to albumin, the affinity of the latter for
thrombin is so increased that the thrombin will be combined with the heparin-albumin compl ex before it can

-4-6react with fibrinogen.

Thus heparin converts the normal

antithrombin of the blood into an anticoagulant.
albumin to

67° c.

Heating

causes it to lose its ability to

neutralize thrombin and the addition of heparin no longer
has any effect on the coagulation of the blood.
itself is not an antithrombin.

Heparin

Heparin has found use

clinically in prevention of venous thrombosis, in vascular _surgery, in rendering blood incoaguable for transfusions, and may possibly have a future place in prevention of peritoneal adhesions.
The circulating blood is thus ever capable of coa gulating but maintains its fluidity in vivo due to the
absence of free thromboplastin, to the integrity of the
endothelial surfaces, and possibly to the action of
anticoag~lant substances.

An upset in this delicate

balance may initiate fibrin-precipitation.

IV.

AGGLUTINATION MECHANISM
General Observations

"The view that increased coagulability of the blood
is an essential point for the production of thrombosis,
has been strongly upheld, especially by clinical observers.

The existence of tnis increased coagulability,

and the likelihood that it is a promoting factor, or,
better, an accompanying phenomenon of thrombosis, cannot
be denied ••• In human beings the occurrence of fibrin
coagulation is not the first stage of thrombosis, but ••.
important changes in the morphological blood constituents precede it. 11 (6) Thus does Aschoff introduce the
phenomenon of agglutination, simultaneously stressing
its importance.

Agglutination, or conglutination, is

the process of clumping of blood-elements--erythrocytes,
leucocytes, or platelets--and the formation therefrom
of an intravascular mass not dependent upon the existence
of strands of fibrin for its framework.
iahn (132) in 1g75 was the first to study the
mechanism 6f thrombosis.

He observed that accumulations

-4-eof white cells appear on the wall of a blood vessel at
a point of injury or on the surface of a foreign body
exposed to the circulating bloodstream.

Several years

later Hayem (49) recognized the importance of platelets
in the formation of agglutinative thrombi; these were
visualized in lesions of arterial walls.

In 1886 Eberth

and Schimmelbusch (36) asserted that a white thrombus
is not a coagulurn but rather a conglutination process .
Such a thrombus, they believed, was formed by the adhesion of both white cells and platelets to the damaged
vess~l wall at the sight of injury; they ascribed the
aggregation of platelets to a "viscous metamorphosis"
of these elements produced by such various thrngs as
contact with diseased or injured vascular walls and with
foreign substances.

They believed that in the actively

circulating blood the corpuscles are separated from the
vessel wall by a clear tube of plasma containing an occasional white corpuscle, that in the slower circulation
the platelets and leucocytes move to the periphery, and
thus that in a sluggish circulation and at the sight of
an injury the platelets tend to adhere to the injured
endothelium and to each other.

The occasional presence

of a red or white corpuscle in the mass of platelets
was purely accidental and was not to be regarded as an

-4-9essential constituent of the primary thrombus.

In his

study of the properties of platelets, Osler (84-) found
that they possessed a noticeable tendency to attach
themselves to foreign particles as evidenced by their
adherence to a fine thread of cotton or linen inserted
into the bloodstream.

He could find no tendency to

Rouleaux-like formations of these elements.
Loeb (63) has studied the comparative pathology of
thrombosis whereby he bas succeeded in throwing considerable light upon the relative i~portance of the processes of agglutination and coagulation.

The former

mechanism being the more primitive, he selected the
blood of the Limulus polyphemus, an arthropod, in which
fibrinogen is lacking and which contains only the one
type of cell, the amebocyte, as best suited for such a
study.

Normally, these cells are not sticky and float

free in the bloodstream.

If such blood is withdrawn

from the animal and placed in a dish without special
precautions, the otherwise elliptical blood-cells round
off; the cytoplasm takes up fluid; the amebocytes stick
together to form a clot-like material filling the
vessels, but which resembles normal bloodclots in that
it gradually retracts.

Such clots have been shown to

consist merely of agglutinated amebocytes, due to changes

-50occurring in the hyaline ectoplasm of these cells.
Another phenomenon observed is the formation of pseudopods by the protoplasm of many. cells or the drawing out
of the whole amebocyte into long fibers which become
elastic and retract in the same manner as true fibrin.
Thus a pseudocoagulation based on agglutination is seen
to occur in this particular species.
If, however, the blood of the Limulus is collected
with care and not allowed to flow over rough surfaces,
the above changes can be· avoided and the amebocytes are
collected almost unchanged.

Instead of forming a clot,

the cells roW1d off and slowlf sink down to the bottom
of the container where they adhere to one another to
form a tissue-like layer of agglutinated cells.

This

tissue represents the most simple type of agglutination
process.
In the study of vertebrate blood, cel ls analogous
to the amebocyte are found--the spindle cells of the
lower classes and the platelets of the mammals.

In

avian blood the cells may remain unclotted for some time
outside the body if they are protected from contact with
tissue elements.

Microscopic examination of such blood

reveals clumps of non-hemoglobin containing mononucleated cellular elements agglutinated to one anotner and

-51adherent to the wall of the container.

This observation

would indicate that in vertebrate blood, as well as in
that of lower animals, agglutination of cellular elements
may precede, and occur independently of, coagulation
processes.

Loeb (65) made similar studies on the blood

of rats, cats, guinea pigs, and rabbits wherein he disclosed that similar conditions occur, that tne blood
platelets would agglutinate independently of the processes of fibrin precipitation.
txperimental observations (106) have been made of
the in vivo processes of agglutination.

Introduction

of a thread or foreign body into the bloodchannels of
Limulus is responsible for the aggregation of numerous
amebocytes on the rough surfaces; the mechanism is the
same as that of the in vitro agglutination.
Comparative investigations have _shown, then, that
during the phylogenetic evolution of animals there have
been developed two processes by which the body reacted
against interfe~ences with the blood or body fluids:
an agglutination of cellular elements, and a conversion
of a soluble constituent of the plasma, the fibrinogen,
into a coagulum.

The former mechanism developed first,

is the only one present in the lower forms, and is retained in the higher forms where it precedes coagulation.

-52The latter is tne more predominating mechanism in t~e
higher classes of animals.
Theories of itiology
Three tneories have been advanced to explain the
mechanism of cellular conglutination:

changes in the

ectoplasmic layers of the cells; changes in the electrical charges of their surfaces; and deposits of proteinsubstances upon their surfaces.

None of these theories

is completely convincing.
A.

The first theory assumes that agglutination

is due to changes in the ectoplasmic layer of the cells
which causes them to become sticky.

The processes

leading to agglutination are closely identified with
those producing ameboid movement in the cells.

In ame-

boid movement a rhythmic wave-like softening and hardening of the ectoplasmic cell layer occurs which are believed due to changes in the fluid content and viscosity
of the protoplasm .

In agglutination it is the first
(

phase, or softening of the ectoplasmic layer, due to
imbibition of fluid, which increases the fluidity of the
cell and is the essential factor.

Loeb (63) in his

study of Limulus concludes that it is primarily a change
in the environment of the amebocytes which causes alterations in the consistency of the ectoplasm underlying
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It is assumed

that conditions are similar in the case of the spindle
cells of the lower vertebrates and of the mammalian
tnrombocytes.
Tne normal amebocytes float free in the bloodstream;
they stick neither to each other nor to the wall of the
vessel.

But physical changes such as contact with rough

surfaces causes them to send out pseudopods and to become sticky, so that they now adhere to the foreign body
and to each other.

Chemical environmental changes also--

such as, pH variations, preponderance of certain cations
and anions, changes in surrounding osmotic pressure, and
the action of certain organic compounds--indicate that
various factors affect in a similar way a.meboid movement
and cell agglutination.

All factors tending to produce

a hardening of the prot oplasm (as increased hydrogen ion
concentration) serve to slow the movement of the cell,
increase the state of contraction, and at the same time
to diminish agglutinability.

Those conditions, on the

other hand, that produce a softening of the protoplasm
(as hypotonic solutions) favor pseudopod extension and
increase aggl utination.

Ameboid movement itself is as-

sociated with and depends upon a stickiness of the ectoplasmic layer; witnout these changes locomotion would
be impossible.
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The second theory holds that it is changes

in the electrical charges of the surface of the cells
which prevents the mutual repulsion of like charges and
results in agglutination.

Michaelis (7g) and others

studied this process by the use of bacterial suspensions
and agglutinating sera.

Normally , the erythrocytes and

platelets have a negative charge and so repel each
other, remaining in suspension.

It is therefore assumed

that it is the loss of the surface charge which results
in agglutination .

The surfaces of the cells are said

to adsorb globulin and fibrinogen (the closer the re'
spective iso-electric point is approached,
the greater

the adsorption) and so effect the discharge.

Therefore,

an increase in these proteins, as seen in some disease
processes, supposedly leads to increased agglutinability.
Red cells are less agglutinable than thrombocytes because of their normally higher electrical charge.
Objections have been raised to this theory (106).
First , the experimental conditions used in support of
this hypothesis require a pH range of around four, a
degree of acidity which is never found within the bloodstream of the living or ganism.

Second, conditions are

not the same in the case of agglutination of bacterial
suspensions on the one hand and of blood elements of
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In the latter instance

agglutination occurs between all kinds of surfaces, not
just between cells.
C.

The third theory of cellular agglutination

suggests that the process is due entirely to a deposit
of a protein-substance, or perhaps a lipoid, on the surfaces of the cells producing adhesiveness.

Apitz (4)

would ascribe this phenomenon to the concentration of
profibrin on the outer portions of the cells.

Abram-

son (1), after a study of the catapnoretic velocities
of the various cellular elements of the normal blood,
states that no change in electrokinetic potential is
necessary for the establishment of a state of aggregation; he feels, rather, that this phenomenon is exp l ainable purely on a mechanical basis, that the platelets are extremely sticky due to their adherence to a
protein film.

He goes fu rt her to apply tne same con-

ception to the subsequent addition of leucocytes and
even to the attacnment of fibrin strands.
Silberberg (106) notes several objections to this
theory also .

The protein films, he finds, are due

either to a liberation from dead cel l ular material or
to coagulative processes resulting in fibrin deposition.
His experiments with amebocytes reveal that no protein
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initiate the process of agglutination.
Thus the exact mechanism of agglutination of cellular elements is unknown.

Fenn (41) combines the con-

ception of surface tension, changes in the consistency
of the protoplasm, and "other factors" in his conclusions as to mechanism .

Perhaps future studies will

find this conception to be more nearly accurate.
Types of Agglutinative Thrombi
The various types of blood cells or parts of cells
may enter into agglutination .

Hence, several types of

agglutination thrombi are recognized.
A.

Platelet-thrombus.

It is explained above

how the amebocytes of Limulus form an agglutination
thrombus upon the introduction of a foreign body into
the bloodstream of this organism; this process represents the prototype of a pure agglutination thrombus.
In the more highly developed species this type of intravascular clot is seen alone more rarely.

Samuel (95)

and Zahn (132) found in Amphibia that physical irritations, particularly heat, may cause an agglutination
of the spindle cells in the vessels of tne tongue and
the mesentery; these cells, axially located, are thrown
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These same investi-

gators in their study of mammals observed agglutination
of thrombocytes in the web of bats and in the mesentery
of rabbits and dogs independently of' fibrin precipitation.

Silberberg (106) observed the agglutination of

thrombocytes in the mesentery and jugular veins, following application of mechanical irritants or the introduction of wettable foreign bodies, especially if a
simultaneous retardation of the blood current had been
induced.

Application of such irritating chemical com-

pounds as silver nitrate, Lugol's solution, carbolic
acid, or turpentine to the outside of the vessel wall
in order to induce endothelial damage provides conditions which favor an adherence of platelets to the
injured wall as well as to each other; sometimes no
lesion of the endothelial wall is visible.

Such thrombi

are found most usually in the pulmonary capillaries or
in the veins of the spleen, in areas therefore where
the blood current is relatively slow.

Thrombosis, on

the other hand, does not occur where complete stoppage
of the bloodflow is produced by means of a double ligature (11).

Thus, it is safe to assume that the blood-

current has to be maintained to a certain extent in
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cellular elements.
B.

Erythrocyte-thrombus.

Red cells, as well

as platelets, may come together to form typical agglutination thrombi.

The underlying mechanisms in the case

of each cell-type may be similar though the precipitating factors may differ.

Loeb, Strickler, and

Tuttle (66) stated that the death in rabbits which had
been injected with beef sera was due to agglutination
of red blood cells i n the pulmonary vessels with resultant asphyxia .

Fibrin played no part in this reaction

though they did find that similar injection of dog serum
produced fi brin plugs .

Rabinovitch (92) obtained like

results by the intravenous injection of ox serum into
rabbits; he could not prevent the formati6n of these
thrombi by heparinization of the animal and concluded
that coagulative mechanisms were here non-functional.
The injection of washed red blood cells or foreign proteins into rabbits was observed by Coca (24) to produce
an agglutination of red corpuscles in the capillaries
and arterioles of the lung.

He attributed this -response

partly to the muscular constriction of these arteries
similar to tnat of anaphylaxis; the rabbits used in his
experiments had been previously sensitized against the
substance used for injection.
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cells in vivo is not uncommon in infectious diseases,
that such thrombi, when old or compact, present a hyaline
appearance and are known as

11

hyaline thrombi".

He

further stated that other alterations of the blood besides infections may produce agglutinative thrombi, citing
as an example the rapid production of such thrombi by
poisons which destroy corpuscles .

In his study of the

suspension stability of the blood, Fahraeus

(39) de-

termined that an increased sinking velocity of red cells
and an increased percentage of serum globulin and fibrinogen occurred coincidentally, that the maximum stability was found in albumin solutions.

Therefore, he

concluded that erythrocyte agglutination must be considered as an important etiological factor of thrombosis
when the globulin-fibrinogen fracti on is increased, as
in infectious diseases.

Ploman (SS) demonstrated oph-

thalmoscopically the increased red cell aggregation in
the vascular bed following digital pressure on the eyeball in individuals with high sedimentation rates as
compared to normals.

These aggregations were said to

endure even in t he face of a rapidly streaming blood
current.

Knisely, Stratman-Thomas, and iliot

(59)

studied the capillary circulation of monkeys infected
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They

state that the normal red cells are not fibrin-coated,
do not stick together or to the endothelium, and are
not phagocytosed by the liver and spleen.

The para-

sitized red cells, however, are coated with fibrin or
a fibrin-like substance and do stick to each other but
not to the endothelium; the clumps so formed are phagocytosed by the liver.

Thus agglutinative red cell

thrombi are possible and do form.

c.

Leucocyte-thrombus.

The occurrence of a

true agglutination of white cells in the living organism
has not as yet been proved .

In the formation of the

other types of thrombi a secondary inclusion of some of
the white cells often takes place; it is the agglutination of the platelets and erythrocytes respectively
which has been considered the essential factor.

The

mononuclear white cells participate in the organization
of the clot while the polymorphonuclear cells may aid
liquefaction.
There exists, according to Tait (115), a definitely
balanced relationship re garding adhesiveness between
individual blood cells and other objects with which they
may come in contact.

He stresses the importance of the

recognition of the "differential adhesiveness" of the
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With full understanding of this factor, the relationship
of the various types of thrombi and their comparative
importance may approach a solution.
Experimental Evidences
Thrombosis in the human begins with agglutination;
fibrin production follows.

Proof of this was adduced by

Osler (S5) in 18$6 when, upon insertion of a string into
the femoral vein of animals, he found that innumerable
cells, almost exclusively platelets, soon adhered to it.
When the string containing these cell-aggregations was
thereupon inserted into a coaguable solution., clotting
occurred, interpreted as due to liberation of fibrin
ferments.

These experimental results would indicate that

such aggregations of thrombocytes wi t'h in the vascular
channel are capable of initiating the precipitation of
fibrin.

Osler further observed that plate lets first

settle upon the edges of a torn or injured vessel and
"form the basis of the thrombus."

He found white thrombi

to be attached to atheromas, aneurysms, and valvular
vegetations, the portion in contact with the bloodstream
being composed of recognizable platelets, the deeper
portion consisting of platelets which had undergone granular disintegration.
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following injury to the vessel wall.

There was first an

accumulation of platelets at the site of injury; white
blood cells, which early are present in very small
numbers, increase rapidly and collect at the margins of
the platelet masses and between them; no fibrin appears
until many white cells have accumulated.

Therefore, he

considered fibrin formation as secondary but of great
importance in the growth of the thrombus.

He stated that

human thrombi are still essentially coagulative in nature
though they may start as agglutinative phenomena; there
is no sharp demarcation between these two processes.
Suitable local conditions for initiation of thrombosis,
according to Welch, are alteration of tne vessel wall
and a slowing and irregularity of the circulation.
Shionoya (104,105) observed thrombosis in a specially constructed, transparent, extracorporeal loop which
he inserted into the circulation between the carotid
artery and the jugular vein of rabbits.

This loop con-

sisted of three parts--the arterial cannula, the venous
cannula, and a connecting collodion tube.

He noted that

a few white thrombi would form in the venous cannula and
in the collodion tube within two to three minutes after
the blood began to flow througn the loop.

Because of
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clotting here began as soon as platelets appeared and
even before white thrombi formed.

Those white thrombi

which developed in the arterial portion of the loop
were dislodged by the current only to gather in the constricted portion of the venous cannula or in the collodion tube; fibrin formed around the platelet-thrombi
and obstruction was complete in four to ten minutes.
He also observed that a red thrombus may begin in the
jugular vein following deposition of platelets in the
constricted portion of the venous cannula; this may grow
rapidly extending in the direction of the blood flow.
He concludes that wherever whirlpools, eddies, and stagnation occur, platelets come in contact with foreign
surfaces, agglutinate, and form white thrombi.

This

mechanism initiates the clotting process and a large red
thrombus is built up from this site resulting in obstruction to blood flow.
Best and coworkers (14) repeated Shionoya•s experiments.

They agree that thrombosis begins with platelet

agglutination.

Examination reveals that the platelets

form on the distal or downstream side of the primary
mass, the proximal side changing very little.

They

found that this process took place without marked slowing
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scratch on the wall of the extracorporeal loop.

They

infer from this that local eddy formation is an essential
in the production of white thrombi.

In line with this

conclusion Murray and others (80) employed heparin to
prevent thrombosts following intimal damage, chemically
or mechanically induced.

Though no signs of thrombosis

occurred, microscopic examination of the involved endothelial wall in some cases revealed masses of platelets
filli ng small crevices in the intima.

These results

lend further credence to the close and essential relationship between formation of white thrombi and damage
to the endothelium.
Although long held by clinicians, the view that
thrombosis is primarily dependent upon an increased coaguability of the blood has recently been proved inaccurate.

Many workers have visualized early thrombi and

have found them to be initiated in the aggregation of
cellular elements, usually platelets.

These obser-

vations are far-reaching and highly important in the
readjustment of clinical attitudes and applications.

V.

CLINICAL CONSIDERATIO~S
General Observations

Thrombosis presents a very important problem to the
clinician.

Its incidence and the frequency and nature

of its complications compel a clearer comprehension of
its basic mechanisms.

For sime years certain predispo-

s i ng situations have been recognized and prophylactic
measures applied accordingly.

The following presents a

discussion of these various factors and attempts to
correlate them in the light of the newer concepts.
In 1940 Barker and others (S,9) of the Mayo Clinic
reviewed a series of 172,ggg post-operative cases covering a thirteen year period.

Of this group 1,665

patients, about one per cent, were found to have had
thrombosis with or without embolism.

Though the inci-

dence showed little difference in the various types of
operation, the followi ng were selected as most liable
to this complication:

types of laparotomies in which

operations are done on female pelvic organs, particul arl y when there occurs an injury to or a ligation of
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greater magnitude, in which considerable tissue is removed and in which there is the likelihood of greater
tissue injury; and patients •with carcinoma and those
with infection.

Thrombosis appeared with slightly

greater frequency in women than in men .

The age group

most generally affected in females was that from 40 to

59 and in males from 50 to 69 appearing very rarely in
individuals under twenty.

The obese were more commonly

involved than the nonobese and thrombosis was definitely
of greater fr~quency in those with blood disease, cardiac disease, disease of peripheral veins, severe infections, or carcinoma.
Besides the postoperative appearance of thrombi,
the literature stresses two other conditions in which
this complication appears with sufficient frequency to
warrant careful observation and therapeutic approach .
The first of these is the postnatal patient, especially
anyone who has been actually or potentially infected.
Second, the individual with a recent coronary occlusion
and cardiac infarction; cardiac mural thrombi form in
fifty per cent and the danger of embolism is as high as
fourteen per cent (17).
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studies on the appearance and development of venous
thrombosis.

Bauer (10) has reported a series of almost

six hundred patients in whom phlebography was used as
tne basis for diagnosis of this condition.

His inter-

pretation of the dynamics states that the w4ole process
begins with a thrombus in one of the smaller muscle
veins which then projects into the lumen of a larger
venous trunk.

Here it becomes the starting point of a

deposition thrombus which continues growing upward in
the direction of the blood stream.

The larger veins ,of

the lower extremities become gradually filled until the
lumen is entirely occluded.

Concurrently, in at least

eighty per cent of these cases, there is a longitudinal
growth up the femoral vein.

Tnus this vein will contain,

at a certain stage, freely waving about in the bloodstream, an eel-like formation with a smooth, slippery
surface and up to forty to fifty centimeters in length.
The thrQmbus forms a cast of the lumen of the large vein
though it does not completely occlude it.

The wall of

the vein is not as yet involved and the thrombus is anchored only at its lowermost end far down in the leg.
This unstable situation does not last more than twentyfour to forty-eight hours for within that time one -of
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The waving

thrombus may break off and give rise to an embolus.
More frequently the thrombus continues to grow in thickness, blocks the lumen, involves the endothelium, and
becomes attached to the vascular wall throughout its
length; phlegmasia alba dolens results.

Bauer makes the

suggestion that an aseptic inflammatory process follows
the formation of the clot; in other words, phlebitis is
an effect rather than the cause of the thrombus.
Contrary to this view, Ochsner (83) emphasizes the
importance of differentiating thrombosis associated with
inflammatory process of the vein, thrombophlebitis, from
that type which occurs in the vein without evidence of
inflammation, phleoothrombosis .

He ascribes different

etiological mechanisms to these two forms and stresses
their prognostic and therapeutic differences.

The

patient with thrombophlebitis has many manifestations
of inflammatory changes, as fever, pain, swelling, and
discoloration; prognosis as to life is good but such
sequelae as edema, pain, ulceration, a nd streptococcic
infections are likely.

Phlebothrombosis, on the other

hand, is most generally not clinically recognizable because of its benign course; danger lies in the frequency
of detachment of the clot or portions of it with resultant
pulmonary embolism and sudden death · or infarction.
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These studies on the frequency and danger of thrombotic manifestations call attention to the necessity of
determining those clinically recognizable factors which
occur commonly in thrombosis.

The literature on this

subject indicates a multiplicity in its etiology; several factors in a variety of interrelationships may be
operative.

All of the elements concerned in the coagu-

lation and agglutination mechanisms are normally present
in the bloodstream in proper balance and are capable in
the event of an internal derangement of changing their
form and producing a solid mass.

Three such derange-

ments (S6) may logically be considered as the basis for
the thrombotic mechanism:
1.

Changes in the vessel wall.

2.

Changes in the blood flow.

3.

Changes in the blood itself.

Chan~ i n ~ Vessel Wall
The integrity of the intimal layer of endothel ial
cells has been mentioned as an important factor in the
maintenance of the fluidity of the blood; it presents a
smootn, almost frictionless, protective surface so that
the blood might flow undisturbed through the numerous

-70body channels.

Welch (124) observed the agglutination

of platelets at the site of endothelial damage with the
subsequent occlusion of the vessel by a red thrombus.
Best and coworkers (14) produced experimental thrombi in
the extracorporeal loop and noted that localization was
always at the site of a scratch mark made within the
artificial blood channel.

It is suggested that platelets

become increasingly adherent in the presence of endothelial damage and agglutination follows.

Perhaps local

eddy formation about the site of intimal disruption may
play a part.

Thus it becomes evident that a roughening

of the inner surface of the vessel predisposes to agglutinative phenomena.
Endothelial damage occurs in many clinical situations.

Trauma may lead to a disruption of the endothe-

lium and thrombosis.

Intravascular injection o f ~ -

rosiM solutions produces a chemical injury to the intimal lining .

In spontaneously cc.curring thrornbophlebi tis,

the inflammator~ process is usually the result of involvement of the vein secondary to perivenous lymphangitis,
the bacteria being carried to the vein through the lymphatic system (S3).

In some instances ·there is evidence

that the damage to the vascular lining is due to toxins
ox allerg!£_ sensitizations (120)

rather than to bacteria.
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Atheromatous cha~ in the arterial system--the phagocytosis of lipoid material by macrophages in the intima
with thickening and eventual erosion of the intimal

layer--frequently are the starting points for thrombotic
masses {lS).

Dock (30) finds that the intima of the

coronary arteries is congenitally thicker in males than
in females and that this difference explains the predilection for coronary occlusion in males.

Veins, too,

are subject to sclerotic changes, the so-called Ehlebosclerosis; Levin and Bucy (61) describe this condition
as an increase in collagen particles in the subendothelial portion of the intima resulting in scattered areas
of endothelial swelling.

Excess radiation is also

damaging to vessel linings.
Frykholm (47) considered injury to the endothelium
as the most important factor in the pathogenesis of
thr0mbosis.

In a careful pathological study of thrombi

of the lower extremities following long continued confinement to bed, he cited four areas which are the most
frequent sites of origin of venous thrombosis:

plantar

veins, veins of calf, veins of adductors, and visceral
pelvic veins.

Frykholm postulated that confining a

patient to bed produces a collapse of these mentioned

/
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weight of the leg against the bed and partly because of
lack of muscular action; the result is apposition of the
intimal layers.

Since the vitality of the endothelial

cells depends mostly upon contact with flowing blood, the
cells are deprived of this source of nutrition producing
disturbances in the intimal integrity and subsequent
thrombosis.
Chaggeg_J,JL_the Blq_od Flow
Slowing of the blood stream has been regarded by
practically everyone who has written on the subject as
one of the most important factors in the production of
thrombosis.

Complete stoppage of the flow does not

cause thro.nbi to form as demonstrated by Baumgarten ( 11)
who showed that blood -may be kept stagnant between two
ligatures applied to a vein without clotting if the internal lining of the vessel is unaltered and intact.
Retardation or oscillation of the current provides the
more favorable conditions for thrombus-formation (106).
A constant supply of platelets must be carried past the
site of original deposition in order that the early
thrombus may grow.

The pathological physiology and the

importance of the retar~ed flow have already been discussed.

Aschoff (6) inserted a dam into his experimental
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out of the stream and arranged themselves into structures
analogous to white thrombi.

Shionoya (104) confirmed

this finding in his extracorporeal loop wherein he found
that wherever whirlpools, eddies, and stagnation occur,
platelets come in contact with forei gn surfaces, agglutinate, and form thrombi.

It is therefore assumed

that in those conditions seen clinically in which there
is a concommitant slowing of the bloodstream and the
formation of thrombi, that the mechanism underlying is
that of agglutination of platelets .
There are many clinical conditions in which
thrombus-formation can be attributed mainly to alterations in the blood flow.

~

local change in the caliber

of the lumen of a vessel provides the proper environment
for the retardation of the current.

Local dilatation

of a vessel, as seen in varicose veins, aneurysms, periarteritis nodosa, and venous plexi, is the frequent site
of thrombosis.

One of the physical laws of the motion

of fluids is that velocity is inversely proportional to
the cross-section of the strerun; hence at the site of
dilatation the rate of the blood flow is decreased proportionally as the vessel is widened.

On the other
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to produce a partial obstruction to the free flow of
blood will also result in a denosition
of blood-elements.
..
Examples of this condition are ligation of the vessel;
compression from outside as seen in pregnancy , in the
use of tight binders or bandages, and in certain anatomical situations; and obstruction wi thin the vessel
as in tumor growths, emboli, and foreigri bodies.

~-

paralysis has also been described as a mechanism in
whicn stasis is produced (74,96,97).

Local stasis as

in a localized drop in blood pressure will promote
thrombosis; excellent illustrations of this co?dition
are the formation of mural thrombi within the heart
chamber beneath an area of infarcted muscle which is no
longer contractile or in a fibrillating auricle which
is producing no effective contractions, particularly
when there is an associated mitral lesion •
There are a number of conditions in which a generalized slowing of the rate of blood flow predisposes to
thrombosis.

Patients with enfeebled heart ac.tion who

display a marked hypotension or venous congestion often
are candidates for thrombi.

An anemic condition may

precipitate a depression of cardiac tone, due to inadequate nourishment of the myocardium .

Auricular
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of rhythm and force of beat.

Debilitating diseases and

cachectic states as well as hypothyroidism eventuate in
'

a low metabolic rate and a hypotension sufficient to
reduce the velocity of the blood flow.

Obesity enlarges

the vascular bed to the extent where general ized stasis
may result.

Hyperparathyroidism may lead to slowing of

the bloodstream by a generalized depletion of muscular
tonus.

Studies on the rate of blood flow postoperatively

by Smith and Allen (109) showed that there is a gradual
-increase in the circulation time ( decreased velocity)
beginning the fifth postoperative day and continuing to
the tenth day when the circulation time may reach fifty
per cent of the preoperative level.

Thus the period of

maximal slowing was found to coincide with the period
of phlebitis and pulmonary embolism; these investigators
do not hold that a slowed circulation is the only cause
of thrombosis but they do place a great deal of emphasis
on its importance.

A lower temperature of the skin has

also been shown to decrease rate of blood flow.
Prolonged confinement to bed, postoperati~ely and
in such conditions as typhoid feverr has recently under- '
gone a great deal of study as regards the danger of
thrombosis.

Dock (29) states that the difficulty
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maintained for long periods under anesthesia or sedation.

The low metabolism, shallow respirations, and

decreased muscular tone produce a di minished velocity
of flow in all the vessels of the body.

But the thrombi

in these cases usually localize in the lower extremities.
This fact is explained as follows.

The veins of the

lower part of the body are smaller when the individual
is in the recumbent position than when he is standing
and so the rate of f low is high despite the decreased
volume.

However, elevation of the shoulders produces a

decrease in the velocity as the veins dilate .

Add to

this endothelial damage due to pressure on the veins (47)
and thrombosis is encouraged.

Absence of deep respi-

ration, cough, or bearing down plus a constant elevation
of the heart above the level of the pelvis are then important factors in the genes'is and localization of
thro:nbi.
Changes in the Blood Itself
The two i mportant conditions predisposing to thrombosis, endotnelial disruption and stasis, have been discussed; both of these mechanisms are mainly dependent
upon the agglutination of platelets for their thrombogenic effect.

No less important then are alterations
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as well as in ooaguability.
Changes in the various blood-elements, particularly
in the platelets, in light of the mechanisms discussed
above would be expected to increase the thrombotic tendency.

Wrignt (12$) · demonstrated an increase in the

number and stickiness of the circulating platelets beginning about the fourth postoperative day and reaching
its height at the tenth day, corresponding to the period
of a high incidence of venous thrombosis.

He suggests

that the increased stickiness is due to the rapid liberation of young, and normally stickier, platelets into
the bloodstream.

MacKa,y ( 69) ·states that an increased

number of platelets per se is not sufficient to induce
thrombosis but that it is only one of several variables
which are operative.

He demonstrated increased platelets

during the convalescent stage of acute infectious diseases and at times in chronic myelogenous leukemia,
remission stage of oernicious anemia, post-hemorrhagic
anemias, lobar pneumonia, acute rheumatism, nephritis,
malignancies, and chronic tuberculosJe;.
Alterations in the ruusico-chemical balance of
blood proteins, expecially in those conditions in wnich
there is an increase, relat'ive or absolute:, of the
globulin-fibrinogen fraction, has been mentioned by many
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thrombosis.

Certainly this condition disrupts the

normal colloidal balance of the plasma and in so doing
has a marked effect upon the agglutination of the various
blood-elements.

The theory of agglutinability as pro-

pounded by Michaelis (78) in which electrical charges,
as regulated by the protein balance, are responsible for
the suspension stability of the blood is very applicable
in this situation for explanation of thrombi-formation.
On the other hand, however, there has been a simultaneous
alteration in the factors controlling coagulation.
Shapiro and coworkers (102) have been able to demonstrate
that a change in the prothrombin time of dilute plasma
may be affected by altera~ions in the plasma protein
fraction, thus indicating its importance in the coagulating mechanism.

It is impossible then to determine

which of these two mechanisms is paramount in this situation.

Increase in the globulin-fibrinogen fraction of

the plasma is found in vagotony (114), in Qrotein disintegration as with fever (93), in infectious diseases (26),
trauma (S2), malignant disease, and multiole mye-

-

loma (102).
Modifications in the viscosity of plasma are also

important predisposing factors in the formation of intravascular clots.

Again the disruption of the colloidal
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Some observers (82)

would hold that the change in this condition is also
that of coagulation.

Increase in viscosity produces an

increased resistance to the flow of the blood; perhaps
the mechanisms concerned in stasis or alteration of the
flow are operative here.

Changes in viscosity are seen

in cholera, anhydremia, hyperglobulinemia, leukemia,
polycythemia, and anemia.
Liberation of toxins or toxic products into the
bloodstream may induce thrombosis by any one of several
mechanisms--injury to the vessel wall or increase in
the agglutinative or coagulative capacities of the blood.
The most common examples of conditi ons in which this
factor operates are eclampsia and extensive _b\!r_r1s_.
Whether the marked tendency to thrombosis exhibited in
infections is due to liberation of toxic elements and
resultant change in the coagulative factors is unknown.
Loeb ( 6.4) showed that certain organisms, notably staphylococcus pyogenes aureus, do increase the coagulability
of plasma in vitro.

McLean (76) noted a marked increase

in the ease of producing experimental thrombi in the
presence of infection but was uncertain as to the underlying mechanism.

Silberberg (106) suggests that the

-80effect of in,flammation on thrombosis is non-specific,
the result of complicated changes in the blood-elements
and the blood-fluid as well.

Aside from the thrombo-

phlebitis which is seen in the lower· extremities due to
a perivenous lymphangitis, other inflammatory processes
frequently result in localization of thrombi.

There is

the lateral sinus thrombosis associated with septic processes in and about the ear, pylephlebitis following
peritonitis, and ovarian, hypogastric, and common iliac
involvement following suppurative processes in the puerperal uterus.
Several drug,§_ have also been implicated in the tendency to formation of thrombi.

Though these are rela-

tively few in ·number, the mechanism involved here has
been fairly definitely proved to be coagulative.
deTakats and coworkers (118) and Peters and others (87)
showed that digitalis favors the tendency to thrombosis,
especially in the presence of some of the other factors
above discussed.

Massie (75) suggested a thromboplastic

effect of digitaloids to explain their action.

Methy-

lated xanthines have been shown by Link (62) to decrease
a dicumarol-induced hypoprothrombinemia and by inference
to increase the clotting tendency.

That adrenalin in

small doses shortens the coagulation time to as much as

-Slone-third, probably through liver stimulation, has been
effectively demonstrated by Cannon and Gray (21).

It

follows then that the tendency to thrombosis is increased
by all adrenergic stimuli including fear, apprehension,
pain, nervous strain, and hemorrhage (22,23,117).
Many stimuli, then, may be responsible for the formation of the intravital clot, the most important of
which are retardation of the blood flow, damage to the
endothelial wall, and alterations in the blood constituents.

In all probability, agglutinative changes in the

cellular elements of the blood are primary in the incipiency of the thrombus; what follows is largely coagulative in nature.

These two processes are not sharply

demarcated and tend to overlap.

A more complete under-

standing of these essentials is necessary for a broader
application of therapeusis.

VI.

SUMMARY

The concept of a dual mechanism existing in human
blood subserving the function of hemostasis has added a
great deal to the knowledge concerning thrombusformation.

The cellular elements have been shown, under

certain conditi ons, to clump together and so form a
solid mass of blood cells.

The fluid portion of the

blood has, on the other hand, the ability to transform
fibrinogen, a colloidal sol, to fibrin, a colloidal gel,
and so too to interfere with the fluidity of the blood .
The thrombus has been depicted as consisting of
three parts--the "Kopfteil" or white portion of agglutinated cells; the

11

Schwanzteil 11 , red in color and coagu-

lative in nature; and the

11

Halsteil" or transition zone .

The construction of this mass is dependent upon a primary agglutination followed by subsequent massive coagulation.

The two processes are intimately related in

their function and interaction; each does not occur entirely separately and distinctly from the other .
lapping is an essential part of their function .

Over-

-33"Agglutination is, so to speak, only a means of
creating in the circulating blood conditions which are
necessary to allow the crystallizing out of fibrin, a
process which cannot occur in the circulating blood
under ordinary conditions~" (106)

To prove that agglu-

tination is of primary import in thrombus-formation, it
has been shown that it is this mechanism which is most
liable to disturbance in those conditions wnich display
the clinically highest incidence of thrombosis.

The

main predisposing causes are disruption of the endothelial integrity, retardation of the blood flow, and
changes in the blood itself .

Rarely, if ever, can a

single cause be ascribed to the formation of a thrombus
in a given condition; in all probability the clot is due
to a variety of these factors.

A more complete compre-

hension of these facts should lead to a better understanding of prophylaxis and therapy.

VII.

THERAPEUTIC IMPLICATIO~S

Thrombosis has long been dreaded as an unfortunate,
but nonetheless uncontrollable, compl ication of many
clinical conditions.

With the relatively recent ad-

vances in medical and surgical techniques has come the
attempt to correct and eradicate the unwarranted formation of thrombi.

Such corrective treatment is now

possible with the newer developments:

the etiological

principles are being recognized and specific drugs capable of interfering with thrombotic tendencies are becoming available.

Probably the greatest difficulty

which has confronted the clinician is the lack of premonitory signs preceding thrombosis (110), be it coronary or otherwise.

Certainly eventual control of this

condition will depend less upon intuition and expectancy
and more upon definitive clinical or laboratory diagnostic criteria.
Diagnosis
Several laboratory tests have been recently suggested as possibly aids in early diagnosis.

The most

-85widely used is the determination of prothrombin times
both in dilute and in whole plasma.

Shapiro and co-

workers (100,103) have repeatedly emphasized the importance of these two readings and the difference between
them, suggesting that a reduction of the difference forbodes thromboembolization.

The rationale for this con-

clusion is said to be that dilution of naturally existing
anticoagulants renders them ineffective without concommitant disturbance of the prothrombin mechanism; the
full effects of these anticoagulants is felt on the
whole plasma.

Hence, a reduction in the value of the

difference is indicative of increased prothrombin activity.

However, Shapiro (100) further noted that this de-

termination is invalid in cases of arterial thrombosis
or in embolization other than pulmonary, thus limiting
its value.

Cotlove and Vorzimer (27), on the other hand,

state that the acceleration of the dilute prothrombin
time may precede, coincide with, or follow recognizable
venous thrombosis and so suggest that this phenomenon
may be an effect rather than a cause of the thrombosis,
in that there may be an absorption of circulating anticoagulants at the site of thrombus formation.
Quick (90) notes that the Hirschboeck clot retraction·test. , "i-f .shortened to ten minutes or less, may

-e6- ·
indicate danger of impending thrombosis; he offers no
explanation of this.
the platelets?

Is it the effect of alteration in

Bancroft, Stanley-Brown, and Chargaff (7)

do routine fibrinogen level studies on all postoperative
patients as well as prothrombin time tests.

They be-

lieve that a high fibrinogen suggests the possibility
of infection and the likelihood of thrombophlebitis.
Bauer (10) has studied and used successfully the tech~
nique of phlebography in determining the presence of
venous thrombi of the lower extremities.

He regards

every inexplicable rise of the pulse or temperature
curves or any slight pulmonary symptoms in the postoperative patient as warranting a careful clinical examination of the legs.

But since no subjective or

objective symptoms are frequently manifest, phlebography
is the only certain recourse.

This method may eventu-

ally become important in the diagnosis of venous thrombi.
Propnylactic Therapy
Because preventing thrombosis is far more effective
than treating the condition once it arises, prophylactic
therapy plays an important role in this field.

Many

conditions have been implicated above in their predisposing or etiological relationship to clinical appearance of tnrombi.

Control of as many of these factors

-s7as possible has been found to reduce materially the
incidence of thrombosis.
Many men (29,82,129) have written extensively on
the subject of prophylactic therapy regarding thrombosis,
particularly that occurring postoperatively and postpuerperally.

Most of the recommendations concern the

correction of stasis and of retardation of blood flow.
It is important that early reestablishment of normal
cardiovascular function be undertaken, especially in
older individuals; digitalis and cardiac stimulants are
indicated for this purpose.
have in part the same effect.

Correction of anemias will
Narcosis and sedation

should be eliminated to as great an extent as possible,
particularly in the postoperative patient.

Reduction

of obesity when practicable prior to elective surgery
is well advised.

Elimination of the use of tobacco for

several days before and ten days following operative
procedures will relieve the va$oconstrictive action induced by nicotine.
Postoper-ative positioning of the patient has long
been a moot question.

It is generally agreed that

Fowler's position or any other that produces flexion of
the hips and knees is contraindicated because of interference with the return blood supply from the lower

-ssextremities.

Frequent changes of posture, active con-

traction of the muscleff of the le gs for the pumping action
of the musculature on the blood, and elevation of the
extremities for varying periods of time are generally
accepted principles .

Frykholm (47) suggests raising the

head of the patient 's bed to cause him to bear a portion
of his weight against the footboard, feeling that this
use of the musculature is all-important.

Early ambu-

lation has been among the latest suggestions for the
avoidance of stasis.
Other methods of encouraging a rapid return of
blood from the extremities include frequent deep breathing exercises which, while serving to aerate the lungs,
increases the negative intrathoracic pressure which is
considered an important aid in venous circulation.

Local

warming of the extremities speeds the blood flow through
them (109); application of heat elsewhere to the body
surface does the same thing reflexly.

The use of pre-

parations of thyroid to increase the metabolic rate and
the velocity of the blood has also been advocated (109,
121) but has not been generally accepted.

Avoidance of

increased abdominal pressure due to distention or to the
use of tightly applied binders will keep from impeding
the return of blood from the lower extremities .

Some

-89observers (60,82) suggest the use of pressure bandages
applied from toes to groin; this measure will collapse
potentially dangerous varicoeities, will increase the
flow of blood through the deep veins, and will prevent
the distention of these veins thus lessening the tendency to detachment of loosely adherent thrombi.
The maintenance of a proper fluid and electrolyte
balance will help to combat thrombi due to increased
viscosity and toxins.

All blood dyscrasias should be

corrected at the earliest opportunity if possible.

Foci

of infection are considered detrimental to the individual and may be the source of some thrombi.

All trauma

which is controllable, such as ope rative and puerperal,
should be reduced to a minimum.

The relatively recent

introduction of the antibiotic drugs, sulfonamides and
penicillin, has brought with it a decreased incidence
of thrombosis secondary to septic processes.

Digitalis,

while aiding the stagnant blood flow of a failing heart,
has been shown to be thrombogenic in character;
deTakats (llS) suggests the use of sodium tetrathionate
to oppose this unfavorable property of the cardiac drug.

-90Specific Therapy
Once a thrombus has formed in the veins of the
lower extremities immediate procedures must be instituted to protect against its complications.

Because of

the possibility that a bland thrombus, the so-called
phlebothrombosis, will detach and be .carried to the lung
as an embolus, femoral ligation with or without thrombectomy (S2) has been advised.

In the case of thrombo-

phlebitis the symptoms are usually referable to a reflex
vasoconstriction; regional sympathetic block, ligation
of the vein, and chemotherapy -are suggested treatment.
In the very recent period two drugs, heparin and
dicumarol, which have been demonstrated to have potent
anticoagulant properties have been discovered and isolated.

The mechanism of action of the former has

already been discus sed (page 45).

Dicumarol serves its

function in vivo by its action as a mild liver toxin (54).
It interferes with the formation of prothrombin in this
organ (40), and its action is measured by the prothrombin
time of plasma.

Heparin is effective in vitro; its

action is determined by the change in clotting time.
It has been shown both experimentally and clinically (10,51,70,80,81,110,112) that heparin prevents
the formation of intravenous, intra-arterial, and mural

-91thrombi.

Similar proof (27,2S,119) has been advanced

for the use of dicumarol which, inc .i dentally, has been
shown (130) to have no toxic manifestations in the
human with the exception of a slight diminution in clot
retraction.

Pharmacologically, the main difference be-

tween these two drugs is the onset of the initial action
and the duration of effect.

Heparin acts almost immedi-

ately when given intravenously whereas the action of
dicumarol, orally administered, is delayed for twentyfour to forty-eight hours.

The former is rapidly

destroyed in the body; dicumarol has an extended effect.
But, in light of the discussion above presented,
what rationale has one for the use of either of these
drugs in prevention of the intravital clot?

Their effect

on the coagulative phase is undoubtedly of importance,
but for maximal usefulness it should be proved that they
serve likewise to inhibit agglutination.

Evans (3S)

states that it is not necessary to have a prolonged
clotting time to prevent intravascular thrombosis.
Wright (126) has demonstrated that the adhesiveness of
blood platelets is inversely proporti onal to the concentration of the anticoagulant present regardless of its
mode of acti on.

Along this line Solandt and Best (111)

have effectively demonstrated that though heparin

-92develops its characteristic effect on the clotting time
with very little delay, it also inhibits platelet agglutination after a short period.

Dicumarol, too, has

been shown (113,127) to have a definite effect on retardation of adhesiveness of platelets concommitant with
changes in the prothr ombin time of plasma.

Accepting

these facts, one can readily understand the efficacy of
tnese drugs in their use as anticoagulants.

It has been

further demonstrated by Murray and others (80) that a
damaged intimal surface, prevented from initiating
thrombosis by the use of anticoagulants, will completely
heal in a few days.

Thus these drugs may be assumed to

have a protective effect in this regard also.
Shapiro and coworkers (101) and Link (62) have
shown that the salicylates are complementary to dicumarol
in that they exert a prot hrombinopenic effect on plasma;
acetylsalicylic acid is more potent than the sodium salt
in this re gard.

Restoration of the prothrombin levels

to normal is accomplished by the use of fresh blood
transfusions and large doses of intravenous vitamin K.
Link (62) also states that vitamin C is necessary for
rapid synthesis of prothrombin and that it should thus
be supplied along with vitamin K.

-93The therapeutic measures available to the clinician
are many, particularly of value in ·venous thrombosis and
in conditions known to be associated with a high incidence of intravascular clotting.

An understanding, then,

of the basic principles governing the appearance of
thrombi and a rational application of combative procedures, along with an awareness of its manifestations
and dangers, will go far toward ultimate control of
thrombosis.
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